Research on Genotypic HIV drug resistance mutations  is published in the Indian Journal of Sexually Transmitted diseases and AIDS.  This Journal is Pub Med .This is the research done by us Dr Raj Harjani and Dr Ram Malkani. This shows that there is a primary Genomic drug resistance to HIV where after starting Anti- Retroviral Therapy (ART) we can not achieve complete viral suppression which is expected after 6 months of ART.Hence it is advisable to have Genotypic drug resistance test done in the initial visit and subsequently when treatment fails .

Leave a Reply

Your email address will not be published. Required fields are marked *